BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18941461)

  • 1. Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.
    Vilar E; Scaltriti M; Balmaña J; Saura C; Guzman M; Arribas J; Baselga J; Tabernero J
    Br J Cancer; 2008 Nov; 99(10):1607-12. PubMed ID: 18941461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
    Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
    Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability.
    Ham MF; Takakuwa T; Luo WJ; Liu A; Horii A; Aozasa K
    Cancer Sci; 2006 Mar; 97(3):226-34. PubMed ID: 16542220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
    Vilar E; Bartnik CM; Stenzel SL; Raskin L; Ahn J; Moreno V; Mukherjee B; Iniesta MD; Morgan MA; Rennert G; Gruber SB
    Cancer Res; 2011 Apr; 71(7):2632-42. PubMed ID: 21300766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.
    Alemayehu A; Fridrichova I
    Eur J Hum Genet; 2007 Sep; 15(9):922-9. PubMed ID: 17534377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11.
    Rodriguez R; Hansen LT; Phear G; Scorah J; Spang-Thomsen M; Cox A; Helleday T; Meuth M
    Clin Cancer Res; 2008 Sep; 14(17):5476-83. PubMed ID: 18765539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
    Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
    Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression.
    Sato K; Kitajima Y; Kohya N; Koga Y; Ohtaka K; Miyazaki K
    Anticancer Res; 2007; 27(2):865-72. PubMed ID: 17465213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status.
    Bras-Gonçalves RA; Rosty C; Laurent-Puig P; Soulié P; Dutrillaux B; Poupon MF
    Br J Cancer; 2000 Feb; 82(4):913-23. PubMed ID: 10732766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations.
    Pedroni M; Roncari B; Maffei S; Losi L; Scarselli A; Di Gregorio C; Marino M; Roncucci L; Benatti P; Ponti G; Rossi G; Menigatti M; Viel A; Genuardi M; de Leon MP
    Dis Markers; 2007; 23(3):179-87. PubMed ID: 17473388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.
    Agostini M; Enzo MV; Morandi L; Bedin C; Pizzini S; Mason S; Bertorelle R; Urso E; Mescoli C; Lise M; Pucciarelli S; Nitti D
    Cancer Biomark; 2010; 6(1):49-61. PubMed ID: 20164541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences and evolution of the methods for the assessment of microsatellite instability.
    Laghi L; Bianchi P; Malesci A
    Oncogene; 2008 Oct; 27(49):6313-21. PubMed ID: 18679418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.